Tokyo Tape
Sign in
← Euglena

Half-year report · Q2

2931.TEDINET S100U6LW
Period2024-01-01 → 2024-06-30
Filed2024-08-08
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥23.6bn2024-01-01 → 2024-06-30Cons.Net sales
Revenue¥46.5bn2023-01-01 → 2023-12-31Cons.Net sales (5-year summary)
Revenue¥22.8bn2023-01-01 → 2023-06-30Cons.Net sales
Operating income¥348m2024-01-01 → 2024-06-30Cons.Operating income
Operating income−¥760m2023-01-01 → 2023-06-30Cons.Operating income
Ordinary income¥309m2024-01-01 → 2024-06-30Cons.Ordinary income
Ordinary income−¥1.4bn2023-01-01 → 2023-12-31Cons.Ordinary income loss (5-year summary)
Ordinary income−¥639m2023-01-01 → 2023-06-30Cons.Ordinary income
Profit before tax−¥476m2024-01-01 → 2024-06-30Cons.Income before income taxes
Profit before tax−¥618m2023-01-01 → 2023-06-30Cons.Income before income taxes
Net income (owners)−¥267m2024-01-01 → 2024-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)−¥2.7bn2023-01-01 → 2023-12-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)−¥914m2023-01-01 → 2023-06-30Cons.Profit loss attributable to owners of parent
Net income−¥235m2024-01-01 → 2024-06-30Cons.Profit loss
Net income−¥913m2023-01-01 → 2023-06-30Cons.Profit loss
Total assets¥70.3bnat 2024-06-30Cons.Assets
Total assets¥59.6bnat 2023-12-31Cons.Assets
Total assets¥60.8bnat 2023-06-30Cons.Total assets (5-year summary)
Total liabilities¥39.0bnat 2024-06-30Cons.Liabilities
Total liabilities¥39.4bnat 2023-12-31Cons.Liabilities
Net assets / equity¥31.3bnat 2024-06-30Cons.Net assets
Net assets / equity¥20.2bnat 2023-12-31Cons.Net assets
Net assets / equity¥21.7bnat 2023-06-30Cons.Net assets (5-year summary)
Cash and deposits¥19.1bnat 2024-06-30Cons.Cash and deposits
Cash and deposits¥15.8bnat 2023-12-31Cons.Cash and deposits
Cash & equivalents¥18.9bnat 2024-06-30Cons.Cash and cash equivalents
Cash & equivalents¥15.7bnat 2023-12-31Cons.Cash and cash equivalents
Cash & equivalents¥16.2bnat 2023-06-30Cons.Cash and cash equivalents
Cash & equivalents¥9.8bnat 2022-12-31dCons.Cash and cash equivalents
Operating cash flow−¥16m2024-01-01 → 2024-06-30Cons.Net cash provided by used in operating activities
Operating cash flow¥658m2023-01-01 → 2023-12-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥500m2023-01-01 → 2023-06-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥361m2024-01-01 → 2024-06-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥646m2023-01-01 → 2023-12-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥351m2023-01-01 → 2023-06-30Cons.Net cash provided by used in investment activities
Financing cash flow¥507m2024-01-01 → 2024-06-30Cons.Net cash provided by used in financing activities
Financing cash flow¥5.8bn2023-01-01 → 2023-12-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥6.2bn2023-01-01 → 2023-06-30Cons.Net cash provided by used in financing activities
EPS (basic)¥-2.022024-01-01 → 2024-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-22.762023-01-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-7.882023-01-01 → 2023-06-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio44.5%at 2024-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio33.9%at 2023-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio35.7%at 2023-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2024-01-01 → 2024-06-30¥0
Reconciling Itemsreconcilingrevenue intersegment2024-01-01 → 2024-06-30¥0
Reconciling Itemsreconcilingsegment profit2024-01-01 → 2024-06-30−¥811m
jpcrp040300-q2r_E27054-000Biofuel Businessreportable segmentrevenue2024-01-01 → 2024-06-30¥306m
jpcrp040300-q2r_E27054-000Biofuel Businessreportable segmentrevenue external2024-01-01 → 2024-06-30¥306m
jpcrp040300-q2r_E27054-000Biofuel Businessreportable segmentsegment profit2024-01-01 → 2024-06-30−¥251m
jpcrp040300-q2r_E27054-000Health Care Businessreportable segmentrevenue2024-01-01 → 2024-06-30¥22.0bn
jpcrp040300-q2r_E27054-000Health Care Businessreportable segmentrevenue external2024-01-01 → 2024-06-30¥22.0bn
jpcrp040300-q2r_E27054-000Health Care Businessreportable segmentrevenue intersegment2024-01-01 → 2024-06-30¥0
jpcrp040300-q2r_E27054-000Health Care Businessreportable segmentsegment profit2024-01-01 → 2024-06-30¥1.7bn
jpcrp040300-q2r_E27054-000Others Businessreportable segmentrevenue2024-01-01 → 2024-06-30¥1.3bn
jpcrp040300-q2r_E27054-000Others Businessreportable segmentrevenue external2024-01-01 → 2024-06-30¥1.3bn
jpcrp040300-q2r_E27054-000Others Businessreportable segmentsegment profit2024-01-01 → 2024-06-30−¥242m
Total Of Reportable Segments And Otherssegment totalrevenue2024-01-01 → 2024-06-30¥23.6bn
Total Of Reportable Segments And Otherssegment totalrevenue external2024-01-01 → 2024-06-30¥23.6bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2024-01-01 → 2024-06-30¥0
Total Of Reportable Segments And Otherssegment totalsegment profit2024-01-01 → 2024-06-30¥1.2bn
Reconciling Itemsreconcilingsegment profit2023-01-01 → 2023-06-30−¥862m
jpcrp040300-q2r_E27054-000Biofuel Businessreportable segmentrevenue2023-01-01 → 2023-06-30¥901m
jpcrp040300-q2r_E27054-000Biofuel Businessreportable segmentrevenue external2023-01-01 → 2023-06-30¥901m
jpcrp040300-q2r_E27054-000Biofuel Businessreportable segmentsegment profit2023-01-01 → 2023-06-30−¥432m
jpcrp040300-q2r_E27054-000Health Care Businessreportable segmentrevenue2023-01-01 → 2023-06-30¥20.5bn
jpcrp040300-q2r_E27054-000Health Care Businessreportable segmentrevenue external2023-01-01 → 2023-06-30¥20.5bn
jpcrp040300-q2r_E27054-000Health Care Businessreportable segmentsegment profit2023-01-01 → 2023-06-30¥724m
jpcrp040300-q2r_E27054-000Others Businessreportable segmentrevenue2023-01-01 → 2023-06-30¥1.4bn
jpcrp040300-q2r_E27054-000Others Businessreportable segmentrevenue external2023-01-01 → 2023-06-30¥1.4bn
jpcrp040300-q2r_E27054-000Others Businessreportable segmentsegment profit2023-01-01 → 2023-06-30−¥189m
Total Of Reportable Segments And Otherssegment totalrevenue2023-01-01 → 2023-06-30¥22.8bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-01-01 → 2023-06-30¥22.8bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-01-01 → 2023-06-30¥101m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 659
ItemContextValueUnit
Payments for sales of investments in subsidiaries resulting in change in scope of consolidation inv cfPrior1YTDDuration－JPY
Payments for sales of investments in subsidiaries resulting in change in scope of consolidation inv cfCurrentYTDDuration-505000000JPY
Proceeds from purchase of investments in subsidiaries resulting in change in scope of consolidation inv cfPrior1YTDDuration－JPY
Proceeds from purchase of investments in subsidiaries resulting in change in scope of consolidation inv cfCurrentYTDDuration47000000JPY
Net cash provided by used in investment activitiesPrior1YTDDuration-351000000JPY
Net cash provided by used in investment activitiesCurrentYTDDuration-361000000JPY
Increase decrease in short term loans payable fin cfPrior1YTDDuration-183000000JPY
Increase decrease in short term loans payable fin cfCurrentYTDDuration1059000000JPY
Proceeds from long term loans payable fin cfPrior1YTDDuration100000000JPY
Proceeds from long term loans payable fin cfCurrentYTDDuration383000000JPY
Repayment of long term loans payable fin cfPrior1YTDDuration-1481000000JPY
Repayment of long term loans payable fin cfCurrentYTDDuration-1929000000JPY
Proceeds from issuance of bonds with subscription rights to shares fin cfPrior1YTDDuration4800000000JPY
Proceeds from issuance of bonds with subscription rights to shares fin cfCurrentYTDDuration－JPY
Proceeds from issuance of bonds fin cfPrior1YTDDuration－JPY
Proceeds from issuance of bonds fin cfCurrentYTDDuration1000000000JPY
Proceeds from issuance of subscription rights to shares fin cfPrior1YTDDuration1000000JPY
Proceeds from issuance of subscription rights to shares fin cfCurrentYTDDuration－JPY
Proceeds from issuance of common stock fin cfPrior1YTDDuration2962000000JPY
Proceeds from issuance of common stock fin cfCurrentYTDDuration－JPY
Purchase of treasury stock fin cfPrior1YTDDuration-0JPY
Purchase of treasury stock fin cfCurrentYTDDuration－JPY
Repayments of lease obligations fin cfPrior1YTDDuration-4000000JPY
Repayments of lease obligations fin cfCurrentYTDDuration-5000000JPY
Net cash provided by used in financing activitiesPrior1YTDDuration6195000000JPY
Net cash provided by used in financing activitiesCurrentYTDDuration507000000JPY
Effect of exchange rate change on cash and cash equivalentsPrior1YTDDuration0JPY
Effect of exchange rate change on cash and cash equivalentsCurrentYTDDuration5000000JPY
Net increase decrease in cash and cash equivalentsPrior1YTDDuration6344000000JPY
Net increase decrease in cash and cash equivalentsCurrentYTDDuration134000000JPY
Cash and cash equivalentsPrior2YearInstant9814000000JPY
Cash and cash equivalentsPrior1YearInstant15651000000JPY
Increase decrease in cash and cash equivalents resulting from change of scope of consolidation ccePrior1YTDDuration－JPY
Increase decrease in cash and cash equivalents resulting from change of scope of consolidation cceCurrentYTDDuration3129000000JPY
Cash and cash equivalentsPrior1QuarterInstant16158000000JPY
Cash and cash equivalentsCurrentQuarterInstant18915000000JPY
Salaries and allowances sgaPrior1YTDDuration1615000000JPY
Salaries and allowances sgaCurrentYTDDuration1695000000JPY
Advertising expenses sgaPrior1YTDDuration5458000000JPY
Advertising expenses sgaCurrentYTDDuration5366000000JPY
Research and development expenses sgaPrior1YTDDuration591000000JPY
Research and development expenses sgaCurrentYTDDuration405000000JPY
Depreciation sgaPrior1YTDDuration1098000000JPY
Depreciation sgaCurrentYTDDuration857000000JPY
Direct salesPrior1YTDDuration_jpcrp040300-q2r_E27054-000HealthCareBusinessReportableSegmentsMember16590000000JPY
Direct salesPrior1YTDDuration_jpcrp040300-q2r_E27054-000BiofuelBusinessReportableSegmentsMember－JPY
Direct salesPrior1YTDDuration_jpcrp040300-q2r_E27054-000OthersBusinessReportableSegmentsMember－JPY
Direct salesPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember16590000000JPY
Direct salesPrior1YTDDuration_ReconcilingItemsMember－JPY
Direct salesPrior1YTDDuration16590000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2023-12-31pass rounding
balance sheet identityconsolidated 2024-06-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-12-31pass
statement vs summary · net assetsconsolidated 2024-06-30pass
statement vs summary · net income attributable to parentconsolidated 2023-01-01/2023-06-30pass
statement vs summary · net income attributable to parentconsolidated 2024-01-01/2024-06-30pass
statement vs summary · operating cash flowconsolidated 2023-01-01/2023-06-30pass
statement vs summary · operating cash flowconsolidated 2024-01-01/2024-06-30pass
statement vs summary · revenueconsolidated 2023-01-01/2023-06-30pass
statement vs summary · revenueconsolidated 2024-01-01/2024-06-30pass
statement vs summary · total assetsconsolidated 2023-12-31pass
statement vs summary · total assetsconsolidated 2024-06-30pass